

The Human Side of AI Agents: Why Every Deployment Is a Workforce Redesign
In this episode of the Disambiguation podcast, host Michael Fauscette talks with Julia Samoylenko, Founder and CEO of Asteri AI, about why deploying AI agents without redesigning the workforce around them is a missed opportunity, how her platform embeds workforce redesign directly into the product rather than leaving it as a customer problem, and what it actually takes to orchestrate humans and AI agents as a governed team inside highly regulated life sciences organizations. Julia spent 11 years at Medtronic in cross-functional roles across multiple regions, most recently as Director of Transformation, before founding Asteri AI in Silicon Valley. The company builds what she calls an AI operating system for life sciences, a platform that enables enterprises to run humans and AI agents as one governed workforce. Asteri AI maps how work gets done across the enterprise, identifies where agents would perform best, and then orchestrates the resulting human-AI team with built-in governance, traceability, and continuous measurement. The conversation covers why deploying agents without understanding the full picture of work leads to fragmented results, how Asteri AI starts by mapping work across the enterprise before proposing which agents to deploy and where, why workforce redesign should be built into the product rather than treated as a separate consulting engagement, what a governed human-AI workforce looks like in practice with full traceability of every agent action and human approval points at every step, how the platform automatically proposes agent deployment based on where inefficiencies exist and where AI would have the most impact, why measurement should focus on capacity increase rather than cost savings alone, how agent work differs across regulatory submissions, clinical operations, and quality and safety, why life sciences leaders need to think beyond single agents and take a systems view of their entire function, and why change management for AI is a continuous process rather than a one-time event. Timestamps:00:00 - Introduction00:31 - Episode title and guest intro00:45 - Julia's background: 11 years at Medtronic01:19 - What led her to start Asteri AI03:06 - What "AI operating system for life sciences" means04:24 - Increasing capacity through human-AI orchestration05:02 - The holistic view: treating agents as team members05:52 - Company-wide deployment and the work intelligence module06:43 - Continuous value measurement as a differentiator07:57 - Shifting from technology focus to workflow focus08:28 - What a governed human-AI workforce looks like09:56 - Workforce redesign built into the product10:39 - Starting with how work gets done, not with the agents12:16 - Change management: still required but now data-driven13:27 - Deep vertical knowledge as competitive advantage13:44 - Governance and oversight in regulated industries15:40 - Scaling past pilots: capacity and measurement16:43 - Capacity increase vs. cost savings17:07 - Regulatory submissions: measuring throughput and time18:03 - Process simulation for decision makers18:58 - Growing capacity without proportional headcount growth19:32 - How enterprise experience shapes the product and earns trust22:13 - How AI work differs across clinical, regulatory, and quality25:11 - What life sciences leaders should know before deploying agents27:05 - Roles becoming obsolete and new work emerging28:37 - Workflow-first approach vs. technology-first29:00 - Change management as an ongoing process30:42 - Orchestration, governance, and workflow redesign as priorities31:01 - Recommendation: Thomas Otter and Ethan Mollick Guest: Julia Samoylenko, Founder and CEO, Asteri AIHost: Michael Fauscette, CEO & Chief Analyst, Arion Research Subscribe and turn on notifications so you never miss an episode.
- Transcript
















